Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment

Year of publication

2019

Authors

Skaga, Erlend; Kulesskiy, Evgeny; Brynjulvsen, Marit; Sandberg, Cecilie J; Potdar, Swapnil; Langmoen, Iver A; Laakso, Aki; Gaál-Paavola, Emília; Perola, Markus; Wennerberg, Krister; Vik-Mo, Einar O

Organizations and authors

Helsinki University Hospital

Laakso Aki

Gaál-Paavola Emília

Kulesskiy Evgeny

Wennerberg Krister

Perola Markus

Potdar Swapnil

University of Helsinki

Laakso Aki

Gaál-Paavola Emília

Kulesskiy Evgeny

Wennerberg Krister

Perola Markus

Potdar Swapnil

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

Clinical and translational medicine

Parent publication name

Clinical and translational medicine

Volume

Issue

Article number

ISSN

2001-1326

Publication forum

82556

Publication forum level

Open access

Open access in the publisher’s service

Yes

Open access of publication channel

Fully open publication channel

Self-archived

Yes

License of the self-archived publication

CC BY

Other information

Fields of science

Neurosciences; Surgery, anesthesiology, intensive care, radiology

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

United States

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

DOI

10.1186/s40169-019-0253-6

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes